Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

500 rare sarcoma patients enrolled in immune study

NCT ID NCT03967834

First seen Nov 18, 2025

Summary

This study aims to better understand the immune system's role in rare soft tissue sarcomas. Researchers will collect medical information and tumor samples from 500 patients (400 new and 100 from past records) to analyze immune markers and genetic signatures. The goal is to learn how these cancers behave and identify potential targets for future therapies.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EPITHELIOID SARCOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Centre Antoine Lacassagne

    RECRUITING

    Nice, 06189, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Centre Eugene Marquis

    RECRUITING

    Rennes, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Centre Georges François Leclerc

    NOT_YET_RECRUITING

    Dijon, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Centre Jean Perrin

    RECRUITING

    Clermont-Ferrand, 63011, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Centre Leon Berard

    RECRUITING

    Lyon, 69008, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Centre Oscar Lambret

    RECRUITING

    Lille, 59020, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Chu Besancon - Site Jean Minjoz

    RECRUITING

    Besançon, 25000, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Chu Dupuytren

    RECRUITING

    Limoges, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Chu Poitiers

    RECRUITING

    Poitiers, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Chu de Marseille - Hopital de La Timone

    RECRUITING

    Marseille, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hôpital Cochin - Site Port-Royal

    RECRUITING

    Paris, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hôpitaux Universitaires de Strasbourg

    RECRUITING

    Strasbourg, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Institut Bergonié

    RECRUITING

    Bordeaux, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Institut Curie

    RECRUITING

    Paris, France

    Contact Email: •••••@•••••

  • Institut Godinot

    RECRUITING

    Reims, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Institut Gustave Roussy

    WITHDRAWN

    Villejuif, 94805, France

  • Institut Paoli-Calmettes

    WITHDRAWN

    Marseille, 13009, France

  • Institut Universitaire du Cancer Toulouse - Oncopole

    RECRUITING

    Toulouse, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Institut de Cancerologie de L'Ouest - Site Rene Gauducheau

    WITHDRAWN

    Saint-Herblain, 44805, France

  • Institut de Cancerologie de Lorraine

    RECRUITING

    Vandœuvre-lès-Nancy, 54519, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

The condition(s) this trial relates to.

alveolar soft part sarcoma clear cell sarcoma desmoplastic small round cell tumor epithelioid hemangioendothelioma neoplasm with perivascular epithelioid cell differentiation sarcoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.